Please pardon my ignorance but from memory the wording used around the agreement on endpoint seems a bit different than the end of meeting presentation few weeks ago, that time it was said that we just need to agree on endpoints whereas in this one JP said FDA did not agree on endpoints we suggested initially and now we need to prepare and discuss again, similar but still bit different in my views, that explains the delay to me.
Ann: J.P. Morgan Healthcare Conference recap, page-11
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.24 |
Change
0.385(3.00%) |
Mkt cap ! $1.652B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.92 | $4.345M | 331.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 230 | $13.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.24 | 288 | 9 |
View Market Depth
| Last trade - 12.23pm 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |